annual CFF:
$20.52M+$325.77M(+106.72%)Summary
- As of today (May 21, 2025), JAZZ annual cash flow from financing activities is $20.52 million, with the most recent change of +$325.77 million (+106.72%) on December 31, 2024.
- During the last 3 years, JAZZ annual CFF has fallen by -$3.95 billion (-99.48%).
- JAZZ annual CFF is now -99.48% below its all-time high of $3.97 billion, reached on December 31, 2021.
Performance
JAZZ Cash from financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFF:
-$813.47M-$805.19M(-9730.40%)Summary
- As of today (May 21, 2025), JAZZ quarterly cash flow from financing activities is -$813.47 million, with the most recent change of -$805.19 million (-9730.40%) on March 1, 2025.
- Over the past year, JAZZ quarterly CFF has dropped by -$756.91 million (-1338.44%).
- JAZZ quarterly CFF is now -117.44% below its all-time high of $4.66 billion, reached on June 30, 2021.
Performance
JAZZ quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFF:
-$736.40M-$756.91M(-3689.38%)Summary
- As of today (May 21, 2025), JAZZ TTM cash flow from financing activities is -$736.40 million, with the most recent change of -$756.91 million (-3689.38%) on March 1, 2025.
- Over the past year, JAZZ TTM CFF has dropped by -$404.38 million (-121.79%).
- JAZZ TTM CFF is now -115.62% below its all-time high of $4.72 billion, reached on June 30, 2021.
Performance
JAZZ TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
JAZZ Cash from financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +106.7% | -1338.4% | -121.8% |
| 3 y3 years | -99.5% | -200.4% | -120.0% |
| 5 y5 years | +107.0% | -450.8% | -136.7% |
JAZZ Cash from financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -99.5% | +103.9% | -430.1% | at low | -120.0% | +24.2% |
| 5 y | 5-year | -99.5% | +103.9% | -117.4% | at low | -115.6% | +24.2% |
| alltime | all time | -99.5% | +103.9% | -117.4% | at low | -115.6% | +24.2% |
JAZZ Cash from financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$813.47M(+9730.4%) | -$736.40M(-3689.4%) |
| Dec 2024 | $20.52M(-106.7%) | -$8.28M(-103.4%) | $20.52M(-128.7%) |
| Sep 2024 | - | $246.43M(-253.0%) | -$71.52M(-82.0%) |
| Jun 2024 | - | -$161.09M(+184.8%) | -$396.44M(+19.4%) |
| Mar 2024 | - | -$56.55M(-43.6%) | -$332.02M(+8.8%) |
| Dec 2023 | -$305.25M(-42.3%) | -$100.31M(+27.8%) | -$305.25M(+64.7%) |
| Sep 2023 | - | -$78.49M(-18.8%) | -$185.35M(-53.2%) |
| Jun 2023 | - | -$96.67M(+224.5%) | -$395.91M(+37.2%) |
| Mar 2023 | - | -$29.79M(-252.0%) | -$288.47M(-45.5%) |
| Dec 2022 | -$529.49M(-113.3%) | $19.60M(-106.8%) | -$529.49M(-33.5%) |
| Sep 2022 | - | -$289.05M(-2782.1%) | -$795.70M(-18.1%) |
| Jun 2022 | - | $10.78M(-104.0%) | -$971.82M(-126.4%) |
| Mar 2022 | - | -$270.81M(+9.8%) | $3.68B(-7.3%) |
| Dec 2021 | $3.97B(+651.9%) | -$246.61M(-47.0%) | $3.97B(-7.1%) |
| Sep 2021 | - | -$465.18M(-110.0%) | $4.27B(-9.4%) |
| Jun 2021 | - | $4.66B(>+9900.0%) | $4.72B(+579.4%) |
| Mar 2021 | - | $18.28M(-67.3%) | $694.03M(+31.4%) |
| Dec 2020 | $528.07M(-279.8%) | $55.88M(-346.6%) | $528.07M(+37.4%) |
| Sep 2020 | - | -$22.66M(-103.5%) | $384.42M(-0.8%) |
| Jun 2020 | - | $642.53M(-535.1%) | $387.61M(-224.6%) |
| Mar 2020 | - | -$147.68M(+68.2%) | -$311.08M(+5.9%) |
| Dec 2019 | -$293.75M(-38.7%) | -$87.78M(+351.0%) | -$293.75M(-55.0%) |
| Sep 2019 | - | -$19.46M(-65.3%) | -$652.42M(+0.8%) |
| Jun 2019 | - | -$56.15M(-56.9%) | -$646.93M(+15.1%) |
| Mar 2019 | - | -$130.35M(-70.8%) | -$561.90M(+17.3%) |
| Dec 2018 | -$479.13M(+17.1%) | -$446.46M(+3095.4%) | -$479.13M(+559.4%) |
| Sep 2018 | - | -$13.97M(-148.4%) | -$72.66M(+129.5%) |
| Jun 2018 | - | $28.87M(-160.7%) | -$31.66M(-88.5%) |
| Mar 2018 | - | -$47.58M(+19.0%) | -$275.01M(-32.8%) |
| Dec 2017 | -$409.11M(-175.6%) | -$39.98M(-247.9%) | -$409.11M(-24.4%) |
| Sep 2017 | - | $27.03M(-112.6%) | -$541.17M(-265.5%) |
| Jun 2017 | - | -$214.48M(+18.1%) | $327.02M(-36.1%) |
| Mar 2017 | - | -$181.67M(+5.6%) | $511.77M(-5.4%) |
| Dec 2016 | $540.99M(-352.4%) | -$172.04M(-119.2%) | $540.99M(-8.2%) |
| Sep 2016 | - | $895.23M(-3110.7%) | $589.17M(-247.1%) |
| Jun 2016 | - | -$29.73M(-80.5%) | -$400.48M(+10.2%) |
| Mar 2016 | - | -$152.46M(+23.1%) | -$363.52M(+69.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2015 | -$214.32M(-130.1%) | -$123.86M(+31.2%) | -$214.32M(+112.4%) |
| Sep 2015 | - | -$94.42M(-1407.3%) | -$100.90M(-139.3%) |
| Jun 2015 | - | $7.22M(-321.5%) | $256.79M(+22.2%) |
| Mar 2015 | - | -$3.26M(-68.8%) | $210.11M(-70.4%) |
| Dec 2014 | $711.03M(-3080.5%) | -$10.44M(-104.0%) | $711.03M(+2.6%) |
| Sep 2014 | - | $263.27M(-767.3%) | $692.75M(+80.5%) |
| Jun 2014 | - | -$39.45M(-107.9%) | $383.76M(-18.5%) |
| Mar 2014 | - | $497.66M(-1832.6%) | $470.67M(-2073.0%) |
| Dec 2013 | -$23.86M(-105.3%) | -$28.72M(-37.2%) | -$23.86M(-382.1%) |
| Sep 2013 | - | -$45.72M(-196.3%) | $8.46M(-82.6%) |
| Jun 2013 | - | $47.46M(+1414.7%) | $48.69M(-89.6%) |
| Mar 2013 | - | $3.13M(-12.7%) | $469.89M(+4.8%) |
| Dec 2012 | $448.53M(-1455.8%) | $3.59M(-165.4%) | $448.53M(+0.2%) |
| Sep 2012 | - | -$5.49M(-101.2%) | $447.74M(+6.7%) |
| Jun 2012 | - | $468.65M(-2671.5%) | $419.62M(-968.5%) |
| Mar 2012 | - | -$18.23M(-750.7%) | -$48.32M(+46.1%) |
| Dec 2011 | -$33.08M(+20.2%) | $2.80M(-108.3%) | -$33.08M(-7.1%) |
| Sep 2011 | - | -$33.61M(-4774.8%) | -$35.62M(+455.8%) |
| Jun 2011 | - | $719.00K(-124.0%) | -$6.41M(-75.8%) |
| Mar 2011 | - | -$2.99M(-1236.9%) | -$26.47M(-3.8%) |
| Dec 2010 | -$27.53M(-316.8%) | $263.00K(-106.0%) | -$27.53M(+30.1%) |
| Sep 2010 | - | -$4.40M(-77.2%) | -$21.15M(+204.5%) |
| Jun 2010 | - | -$19.34M(+377.8%) | -$6.95M(-155.5%) |
| Mar 2010 | - | -$4.05M(-161.0%) | $12.52M(-1.4%) |
| Dec 2009 | $12.69M(-80.2%) | $6.64M(-32.3%) | $12.69M(+85.8%) |
| Sep 2009 | - | $9.80M(+7620.5%) | $6.83M(-62.5%) |
| Jun 2009 | - | $127.00K(-103.3%) | $18.20M(-14.7%) |
| Mar 2009 | - | -$3.88M(-599.4%) | $21.33M(-66.7%) |
| Dec 2008 | $64.13M(-35.7%) | $776.00K(-96.3%) | $64.13M(-1.3%) |
| Sep 2008 | - | $21.17M(+549.7%) | $64.98M(+52.5%) |
| Jun 2008 | - | $3.26M(-91.6%) | $42.62M(-69.0%) |
| Mar 2008 | - | $38.92M(+2289.4%) | $137.69M(+38.0%) |
| Dec 2007 | $99.75M(-14.9%) | $1.63M(-237.2%) | $99.75M(+1.7%) |
| Sep 2007 | - | -$1.19M(-101.2%) | $98.12M(-1.2%) |
| Jun 2007 | - | $98.32M(+9841.4%) | $99.31M(>+9900.0%) |
| Mar 2007 | - | $989.00K | $989.00K |
| Dec 2006 | $117.19M(-39.2%) | - | - |
| Dec 2005 | $192.85M | - | - |
FAQ
- What is Jazz Pharmaceuticals annual cash flow from financing activities?
- What is the all time high annual CFF for Jazz Pharmaceuticals?
- What is Jazz Pharmaceuticals annual CFF year-on-year change?
- What is Jazz Pharmaceuticals quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Jazz Pharmaceuticals?
- What is Jazz Pharmaceuticals quarterly CFF year-on-year change?
- What is Jazz Pharmaceuticals TTM cash flow from financing activities?
- What is the all time high TTM CFF for Jazz Pharmaceuticals?
- What is Jazz Pharmaceuticals TTM CFF year-on-year change?
What is Jazz Pharmaceuticals annual cash flow from financing activities?
The current annual CFF of JAZZ is $20.52M
What is the all time high annual CFF for Jazz Pharmaceuticals?
Jazz Pharmaceuticals all-time high annual cash flow from financing activities is $3.97B
What is Jazz Pharmaceuticals annual CFF year-on-year change?
Over the past year, JAZZ annual cash flow from financing activities has changed by +$325.77M (+106.72%)
What is Jazz Pharmaceuticals quarterly cash flow from financing activities?
The current quarterly CFF of JAZZ is -$813.47M
What is the all time high quarterly CFF for Jazz Pharmaceuticals?
Jazz Pharmaceuticals all-time high quarterly cash flow from financing activities is $4.66B
What is Jazz Pharmaceuticals quarterly CFF year-on-year change?
Over the past year, JAZZ quarterly cash flow from financing activities has changed by -$756.91M (-1338.44%)
What is Jazz Pharmaceuticals TTM cash flow from financing activities?
The current TTM CFF of JAZZ is -$736.40M
What is the all time high TTM CFF for Jazz Pharmaceuticals?
Jazz Pharmaceuticals all-time high TTM cash flow from financing activities is $4.72B
What is Jazz Pharmaceuticals TTM CFF year-on-year change?
Over the past year, JAZZ TTM cash flow from financing activities has changed by -$404.38M (-121.79%)